Yonhap Infomax NewsJan 23
Stonebridge Ventures has sold part of its Livesmed stake via block deal to a global long-only fund, aiming to stabilize shareholder structure and minimize overhang risk.
#YonhapInfomax #StonebridgeVentures #Livesmed #BlockDeal #LongOnlyFund #ShareholderStructure #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=101753
Stonebridge Ventures Sells Partial Stake in Livesmed via Block Deal to Global Long-Only Fund

Stonebridge Ventures has sold part of its Livesmed stake via block deal to a global long-only fund, aiming to stabilize shareholder structure and minimize overhang risk.

Yonhap Infomax
Yonhap Infomax NewsOct 21
Livesmed Co., a South Korean medical device maker, has filed for a KOSDAQ IPO targeting a 1.4 trillion won ($1.02 billion) market cap, with proceeds to fund production expansion and global sales growth.
#YonhapInfomax #Livesmed #KOSDAQIPO #MarketCapitalization #LaparoscopicInstruments #RevenueGrowth #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=86488
Livesmed Targets 1.4 Trillion Won Market Cap, Files for KOSDAQ IPO

Livesmed Co., a South Korean medical device maker, has filed for a KOSDAQ IPO targeting a 1.4 trillion won ($1.02 billion) market cap, with proceeds to fund production expansion and global sales growth.

Yonhap Infomax